Grant - BioSapien
Investment Firm
Overview
BioSapien is a biotech startup focusing on developing a 3D printed drug delivery platform to provide FDA approved drugs.
Announced Date
Nov 11, 2021
Funding Type
Grant
Highlights
Location
New York, New York, United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
 National Science Foundation |
Round Details and Background
BioSapien raised $256000 on 2021-11-11 in Grant
BioSapien is a biotech startup focusing on developing a 3D printed drug delivery platform to provide FDA approved drugs.
Company Funding History
8
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Nov 11, 2021 |  Grant - BioSapien | 1 | - | 256.0K |
| Nov 01, 2022 | Series A - BioSapien | 3 | - | 35.0M |
| Jul 19, 2023 | Convertible Note - BioSapien | 1 | - | undefined |
| Feb 21, 2024 | Grant - BioSapien | 1 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.